Medtronic plc (MDT)
Medtronic plc is a leading global medical technology enterprise that invents, develops, manufactures, and distributes an extensive range of device-based medical therapies. These solutions serve healthcare systems, clinicians, physicians, and patients across the world. The company's operations are categorized into several key portfolios: Cardiovascular Portfolio: This segment focuses on cardiac health, providing technologies for heart rhythm management, including implantable pacemakers, defibrillators, and monitoring systems, alongside cardiac ablation tools and remote patient software. It also addresses structural heart issues with products like aortic and pulmonary valves, surgical repair devices, and endovascular stent grafts, in addition to offerings for percutaneous coronary interventions (e.g., angioplasty balloons). Medical Surgical Portfolio: Offering a broad spectrum of surgical instruments and therapies, this division includes staples, vessel sealing devices, wound closure products, and electrosurgical equipment. It also pioneers surgical artificial intelligence and robotic-assisted platforms, alongside solutions for hernia repair, gynecology, lung conditions, minimally invasive gastrointestinal and hepatologic diagnostics, patient monitoring, airway management, ventilation therapies, and renal disease. Neuroscience Portfolio: This division delivers specialized products for a diverse group of medical professionals, such as spinal surgeons, neurosurgeons, neurologists, pain management specialists, and ENT experts. Its offerings span energy surgical instruments, advanced image-guided and intra-operative imaging systems, robotic guidance for spine procedures, and therapies targeting the brain's vasculature. Diabetes Operating Unit: Dedicated to diabetes management, this unit provides innovative solutions like insulin pumps and their associated consumables, continuous glucose monitoring (CGM) systems, and smart insulin pen technologies. Established in 1949, Medtronic plc maintains its corporate headquarters in Dublin, Ireland.
Sector: Electromedical & Electrotherapeutic Apparatus
Industry: Medical - Devices
Medtronic plc
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
based on 1.28B shares outstanding
Medtronic plc is a leading global medical technology enterprise that invents, develops, manufactures, and distributes an extensive range of device-based medical therapies. These solutions serve healthcare systems, clinicians, physicians, and patients across the world.
The company's operations are categorized into several key portfolios: Cardiovascular Portfolio: This segment focuses on cardiac health, providing technologies for heart rhythm management, including implantable pacemakers, defibrillators, and monitoring systems, alongside cardiac ablation tools and remote patient software.
It also addresses structural heart issues with products like aortic and pulmonary valves, surgical repair devices, and endovascular stent grafts, in addition to offerings for percutaneous coronary interventions (e.g., angioplasty balloons). Medical Surgical Portfolio: Offering a broad spectrum of surgical instruments and therapies, this division includes staples, vessel sealing devices, wound closure products, and electrosurgical equipment.
It also pioneers surgical artificial intelligence and robotic-assisted platforms, alongside solutions for hernia repair, gynecology, lung conditions, minimally invasive gastrointestinal and hepatologic diagnostics, patient monitoring, airway management, ventilation therapies, and renal disease. Neuroscience Portfolio: This division delivers specialized products for a diverse group of medical professionals, such as spinal surgeons, neurosurgeons, neurologists, pain management specialists, and ENT experts.
Its offerings span energy surgical instruments, advanced image-guided and intra-operative imaging systems, robotic guidance for spine procedures, and therapies targeting the brain's vasculature. Diabetes Operating Unit: Dedicated to diabetes management, this unit provides innovative solutions like insulin pumps and their associated consumables, continuous glucose monitoring (CGM) systems, and smart insulin pen technologies. Established in 1949, Medtronic plc maintains its corporate headquarters in Dublin, Ireland.
Leadership
Geoff Martha
Chairman and Chief Executive Officer
Geoffrey (Geoff) Martha
Chairman and Chief Executive Officer
Michael (Mike) Marinaro
Executive Vice President and President, Medical Surgical Portfolio and Americas
Michelle Quinn
Executive Vice President, General Counsel & Secretary
Employees
95K+
Country
IE
Sector
Healthcare
Website
medtronic.com
| Insider | Title | Type | Shares | Value | Date |
|---|---|---|---|---|---|
| Chairman and CEO | Sale | 50.0K | $4.75M | Oct 15, 2026 | |
| EVP, Pres MedSurg and Americas | Sale | 10.4K | $1.00M | Oct 15, 2026 | |
| Director | Other | 182 | -- | Oct 15, 2026 | |
| EVP & President Cardiovascular | Sale | 1.5K | $138.9K | Sep 16, 2026 | |
| Chief Accounting Officer | Withholding/Transfer | 600 | -- | Sep 15, 2026 | |
| EVP, Pres MedSurg and Americas | Automatic Sell | 1.1K | $100.1K | Aug 20, 2026 |
| Name | Shares | % | Source |
|---|---|---|---|
BlackRock, Inc. | 114.0M | 8.9% | 13F |
BlackRock, Inc. · also on 13F· may incl. warrants· filed Apr 2025 | 88.7M | 6.9% | 13G |
VANGUARD CAPITAL MANAGEMENT LLC | 83.8M | 6.6% | 13F |
STATE STREET CORP | 63.4M | 5.0% | 13F |
VANGUARD PORTFOLIO MANAGEMENT LLC | 34.1M | 2.7% | 13F |
GEODE CAPITAL MANAGEMENT, LLC | 30.2M | 2.4% | 13F |
JPMORGAN CHASE & CO | 27.8M | 2.2% | 13F |
BANK OF AMERICA CORP /DE/ | 21.3M | 1.7% | 13F |
MASSACHUSETTS FINANCIAL SERVICES CO /MA/ | 19.9M | 1.6% | 13F |
MORGAN STANLEY | 19.4M | 1.5% | 13F |
Insiders
- Martha GeoffreyChairman and CEO
- Marinaro MichaelEVP, Pres MedSurg and Americas
- Lofton Kevin EDirector
- KIIL HARRY SKIPEVP & President Cardiovascular
- Blomquist Denise L.Chief Accounting Officer
- Walter Matthew R.SVP, Chief HR Officer
- Pieton ThierryEVP & Chief Financial Officer
- Thompson KweliEVP & President, Neuroscience
- Quinn MichelleEVP, GC and Secretary
- Wall Brett A.EVP & Pres Neuroscience
based on 1.28B shares outstanding
30d Avg
34.28M
60d Avg
21.77M
90d Avg
16.65M